| Age, yr, mean±SD |
42.3±10.0 |
62.4±11.2 |
51.2±14.5 |
61.4±20.4 |
| Gender male/female |
7/8 |
10/1 |
8/7 |
5/4 |
| Mean glomerular filtration rate (ml/min/1.73 m2±SD) |
– |
19.0±7.8 |
– |
– |
| Residual renal function (ml/min) mean±SD |
– |
– |
0 |
5.3±4.8 |
| Mean time on dialysis, months±SD |
– |
– |
55.9±70.5 |
16.1±6.2 |
| Serum Albumin (g/dl) mean±SD |
4.2±0.3 |
4.5±0.2 |
4.1±0.3 |
3.7±0.2 |
| Hemoglobin (g/dl) mean±SD |
12.2±1.1 |
12.8±1.8 |
11.8±1.3 |
12.1±1.1 |
| Leukocytes (109/l) mean±SD |
7.5±1.2 |
7.6±1.1 |
6.21±1.96 |
7.0±1.6 |
| Causes of CKD n (%) |
|
|
|
|
| glomerulonephritis |
|
3 (27.3%) |
4 (26.7%) |
0 |
| interstitial nephropathy |
|
2 (18.2%) |
0 |
0 |
| renal hypoplasia |
|
1 (0.9%) |
0 |
0 |
| polycystic kidney disease |
|
0 |
3 (20.0% |
2 (22.2%) |
| systemic lupus erythematosus |
|
0 |
1 (0.7%) |
0 |
| hemolytic uremic syndrome |
|
0 |
1 (0.7%) |
0 |
| bilateral nephrectomy |
|
0 |
1 (0.7%) |
0 |
| obstructive kidney disease |
|
0 |
1 (0.7%) |
0 |
| nephrosclerosis |
|
0 |
0 |
2 (22.2%) |
| unknown |
|
4 (36.4%) |
4 (26.7%) |
5 (55.6%) |
| Hypertension n (%) |
0 |
9 (81.8%) |
15 (100%) |
4 (44.4%) |
| Use of statins n (%) |
0 |
7 (63.6%) |
5 (33.3%) |
8 (88.9%) |
| Use of vitamin D n (%) |
0 |
8 (72.7%) |
5 (33.3%) |
9 (100%) |
| Use of erythropoietin n (%) |
0 |
3 (27.3%) |
12 (80.0%) |
8 (88.9%) |
| Use of inhibitors of the Renin-Angiotensin System |
0 |
5 (45.5%) |
1 (6.7%) |
4 (44.4%) |
